Standout Papers

Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acu... 2011 2026 2016 2021 561
  1. Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke (2013)
    Jeffrey L. Saver, Gregg C. Fonarow et al. JAMA
  2. Factors Influencing the Decline in Stroke Mortality (2013)
    Daniel T. Lackland, Edward J. Roccella et al. Stroke
  3. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2014)
    Karen A. Hicks, James E. Tcheng et al. Circulation
  4. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment (2015)
    Zahinoor Ismail, Eric E. Smith et al. Alzheimer s & Dementia
  5. Defining hematoma expansion in intracerebral hemorrhage (2011)
    Dar Dowlatshahi, Andrew M. Demchuk et al. Neurology
  6. Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke (2011)
    Gregg C. Fonarow, Eric E. Smith et al. Circulation
  7. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke (2015)
    Bart M. Demaerschalk, Dawn Kleindorfer et al. Stroke
  8. Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative (2014)
    Gregg C. Fonarow, Xin Zhao et al. JAMA
  9. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2014)
    Karen A. Hicks, James E. Tcheng et al. Journal of the American College of Cardiology
  10. Prevalence of Depression in Patients With Mild Cognitive Impairment (2016)
    Zahinoor Ismail, Corinne E. Fischer et al. JAMA Psychiatry
  11. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations (2017)
    Zahinoor Ismail, Luis Agüera-Ortíz et al. Journal of Alzheimer s Disease
  12. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice (2019)
    Reza Jahan, Jeffrey L. Saver et al. JAMA
  13. Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2023)
    Nada El Husseini, Irene Katzan et al. Stroke
  14. Progression of cerebral amyloid angiopathy: a pathophysiological framework (2023)
    Emma A. Koemans, Jasmeer P. Chhatwal et al. The Lancet Neurology

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 114 standout
Sub-graph 1 of 18

Citing Papers

Stroke
2024 Standout
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
83 intermediate papers

Works of Eric E. Smith being referenced

Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association
2017
Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke
2016
and 64 more

Author Peers

Author Last Decade Papers Cites
Eric E. Smith 15705 10454 5016 5353 622 30.7k
L. Jaap Kappelle 14729 7980 3614 3345 484 31.3k
Geoffrey A. Donnan 21025 10250 2204 8152 644 36.3k
Martin Dennis 12877 6273 3328 5818 330 24.9k
Peter J. Koudstaal 12254 8132 6095 2711 444 37.8k
Markku Kaste 22295 10342 2751 8763 367 33.8k
Julien Bogousslavsky 10125 8842 2666 2851 529 25.7k
José Biller 17496 8957 2264 5554 281 29.1k
Craig S. Anderson 12331 9988 3803 6088 547 30.0k
Michael D. Hill 21791 10508 1385 6037 905 41.7k
Larry B. Goldstein 12370 5095 2024 4885 382 26.9k

All Works

Loading papers...

Rankless by CCL
2026